Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle

Comprehensive Arthritis Referral Study — Phase 2: Analysis of the Comprehensive Arthritis Referral Tool

Andrew E. Thompson, Sara L. Haig, Nicole G.H. LeRiche, Gina Rohekar, Sherry Rohekar and Janet E. Pope
The Journal of Rheumatology October 2014, 41 (10) 1980-1989; DOI: https://doi.org/10.3899/jrheum.140167
Andrew E. Thompson
From the Department of Medicine, Division of Rheumatology, Western University, London, Ontario, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: andy.thompson@rogers.com
Sara L. Haig
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicole G.H. LeRiche
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gina Rohekar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sherry Rohekar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janet E. Pope
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Participant disposition of patient referrals received using the Comprehensive Arthritis Referral Tool (CART) between September 2007 and August 2008.

  • APPENDIX 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    APPENDIX 1.

    The Comprehensive Arthritis Referral Tool (CART), a single-page rheumatology referral questionnaire.

Tables

  • Figures
    • View popup
    Table 1.

    Baseline demographics based on grade at consultation (%).

    CharacteristicsOverall, n = 696Urgent, n = 210Non-urgent, n = 486EIA, n = 95Non-EIA, n = 601
    Age, yrs< 2034 (4.9)12 (5.7)22 (4.5)6 (6.3)28 (4.8)
    20–40137 (19.7)42 (20)95 (19.5)20 (21.1)117 (19.4)
    41–60310 (44.5)96 (45.7)214 (44)42 (44.2)268 (44.6)
    > 60215 (30.9)60 (28.6)155 (32)27 (28.4)188 (31.2)
    SexFemale475 (68.2)129 (61.4)346 (71.2)50 (52.6)425 (70.7)
    Male221 (31.8)81 (38.6)140 (28.8)45 (47.4)176 (29.3)
    Duration, mos> 12423 (60.8)102 (48.6)321 (66)17 (17.9)406 (67.6)
    < 12273 (39.2)108 (51.4)165 (34)78 (82.1)195 (32.4)
    Morning stiffness, min> 60313 (45.0)106 (50.5)207 (42.6)55 (57.9)258 (42.9)
    < 60383 (55.0)104 (49.5)279 (57.4)40 (42.1)343 (57.1)
    Prior rheumatologic assessmentYes224 (32.2)76 (36.2)148 (30.5)8 (8.4)216 (35.9)
    No449 (64.5)128 (61.0)321 (66.0)85 (89.5)364 (60.6)
    Not sure23 (3.3)6 (2.9)17 (3.5)2 (2.1)21 (3.5)
    Patient reports swollen jointsYes439 (63.1)160 (76.2)279 (57.4)82 (86.3)357 (59.4)
    No171(24.6)28 (13.3)143 (29.4)4 (4.2)167 (27.8)
    Not sure86 (12.4)22 (10.5)64 (13.2)9 (9.5)77 (12.8)
    Referring physician reports swollen jointsYes341 (49.0)138 (65.7)203 (41.8)73 (76.8)268 (44.6)
    No255 (36.6)42 (20.0)213 (43.8)10 (10.5)245 (40.8)
    Not sure100 (14.4)30 (14.3)70 (14.4)12 (12.6)88 (14.6)
    Difficulty with simple ADLYes435 (62.5)150 (71.4)285 (58.6)72 (75.8)363 (60.4)
    No261 (37.5)60 (28.6)201 (41.4)23 (24.2)238 (39.6)
    Missed or stopped workingYes279 (40.1)94 (44.8)185 (38.1)39 (41.1)240 (39.9)
    No417 (59.9)116 (55.2)301 (61.9)56 (58.9)361 (60.1)
    Personal or family history of psoriasisYes123 (17.7)47 (22.4)76 (15.6)21 (22.1)102 (17.0)
    No573 (82.3)163 (77.6)410 (84.4)74 (77.9)499 (83.0)
    Strong family history of RAYes262 (37.6)68 (32.4)194 (39.9)32 (33.7)230 (38.3)
    No434 (62.4)142 (67.6)292 (60.1)63 (66.3)371 (61.7)
    ESRElevated192 (27.6)90 (42.9)102 (21.0)47 (49.5)145 (24.1)
    Normal or no blood work504 (72.4)120 (57.1)384 (79.0)48 (50.5)456 (75.9)
    CRPElevated138 (19.8)73 (34.8)65 (13.4)40 (42.1)98 (16.3)
    Normal or no blood work551 (79.2)137 (65.2)421 (86.6)55 (57.9)503 (83.7)
    RFPositive156 (22.4)81 (38.6)75 (15.4)39 (41.1)117 (19.5)
    Negative or no blood work540 (77.6)129 (61.4)411 (84.6)56 (58.9)484 (80.5)
    ANAPositive168 (24.1)65 (31.0)103 (21.2)29 (30.5)139 (23.1)
    Negative or no blood work528 (75.9)145 (69.0)383 (78.8)66 (69.5)462 (76.9)
    • ADL: activities of daily life; RA: rheumatoid arthritis; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; RF: rheumatoid factor; ANA: antinuclear antibody.

    • View popup
    Table 2.

    Urgent versus non-urgent referrals at triage versus consultation.

    Consultation GradeTotal
    UrgentNon-urgent
    Triage GradeUrgent169100269
    Non-urgent41386427
    Total210486696
    • View popup
    Table 3.

    Triage urgency grading versus consultation EIA grading.

    Consultation GradeTotal
    EIANot EIA
    Triage GradeUrgent86183269
    Non-urgent9418427
    Total95601696
    • EIA: early inflammatory arthritis.

    • View popup
    Table 4.

    Predictors of urgent versus non-urgent referrals.

    VariableOR95% CIp
    1. Positive RF2.621.70–4.04< 0.001
    2. Referring physician rating the referral as urgent2.051.33–3.15< 0.001
    3. Elevated CRP1.971.23–3.150.005
    4. Patient has seen a rheumatologist before1.801.17–2.770.007
    5. Patient reports a history of joint swelling1.771.09–2.530.021
    6. Duration more than 12 mos1.671.01–2.530.016
    7. Patient reports a personal or family history of psoriasis1.651.03–2.650.037
    8. Family history of RA*0.620.42–0.930.022
    • ↵* Protective, less likelihood of an urgent referral. RF: rheumatoid factor; CRP: C-reactive protein; RA: rheumatoid arthritis.

    • View popup
    Table 5.

    Predictors of early inflammatory arthritis.

    VariableOR95% CIp
    1. Duration less than 12 mos6.163.21–11.84< 0.001
    2. Patient-reported joint swelling3.801.70–8.540.001
    3. Referring physician classifies diagnosis as inflammatory2.481.10–5.610.0293
    4. Referring physician reported referral as urgent2.211.23–3.960.008
    5. Positive RF1.881.01–3.480.046
    6. Morning stiffness > 60 min1.791.02–3.140.044
    7. Patient > 60 yrs of age*0.250.07–0.930.038
    8. Patient previously assessed by a rheumatologist*0.240.10–0.550.001
    • ↵* Protective, less likelihood of early inflammatory arthritis. RF: rheumatoid factor.

    • View popup
    APPENDIX 2.

    Triage grading system.

    CategoryDescriptionExamples
    A+For patients who require assessment and treatment on an urgent basis within 24–48 h. Reserved for patients whose physicians personally contact the rheumatologist to outline clinical details.
    • Septic arthritis

    • Giant cell arteritis

    • CTD with major organ decompensation

    AFor patients who require assessment and treatment on an emergent basis within 2–4 weeks. Reserved for patients with a recent onset inflammatory arthritis where early intervention is critical to a successful outcome.
    • New onset IA

    • Severe IA with impact on ADL

    • CTD

    • Vasculitis

    • PMR

    BFor patients who require assessment and treatment on an elective basis within 2–4 mos. Reserved for patients with information that suggests an inflammatory syndrome where immediate intervention is not necessarily as important, but treatment is necessary.
    • Established IA

    • Undiagnosed or subacute or probable IA

    • Crystalline arthritis

    • Severe OA with a major impact on ADL

    CFor patients who require assessment and treatment on an elective basis within the next 6–12 mos. Reserved for patients with stable treated inflammatory disorders or non-inflammatory disorders.
    • Previously diagnosed rheumatic disease (stable) referred for diagnostic re-evaluation or review of treatment

    • FM not previously seen by rheumatologist

    • Possible IA, but not deemed highly likely

    • OA which may benefit from consultation

    DFor patients with a problem which is best assessed by another healthcare provider. Appointments are not given unless discussed with referring physician. Reserved for patients with established chronic pain conditions who would be better treated by specialists in orthopedics, chronic pain, or rehabilitation.
    • Diagnosed FM

    • Chronic MBP

    • Soft tissue pain

    • CTD: connective tissue disease; IA: inflammatory arthritis; PMR: polymyalgia rheumatica; ADL: activities of daily living; OA: osteoarthritis; FM: fibromyalgia; MBP: mechanical back pain. From: Graydon SL, Thompson AE. J Rheumatol 2008;35:1378–83.

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 41, Issue 10
1 Oct 2014
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comprehensive Arthritis Referral Study — Phase 2: Analysis of the Comprehensive Arthritis Referral Tool
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Comprehensive Arthritis Referral Study — Phase 2: Analysis of the Comprehensive Arthritis Referral Tool
Andrew E. Thompson, Sara L. Haig, Nicole G.H. LeRiche, Gina Rohekar, Sherry Rohekar, Janet E. Pope
The Journal of Rheumatology Oct 2014, 41 (10) 1980-1989; DOI: 10.3899/jrheum.140167

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Comprehensive Arthritis Referral Study — Phase 2: Analysis of the Comprehensive Arthritis Referral Tool
Andrew E. Thompson, Sara L. Haig, Nicole G.H. LeRiche, Gina Rohekar, Sherry Rohekar, Janet E. Pope
The Journal of Rheumatology Oct 2014, 41 (10) 1980-1989; DOI: 10.3899/jrheum.140167
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgment
    • APPENDIX 1.
    • APPENDIX 2.
    • Footnotes
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters

Keywords

ARTHRITIS
TRIAGE
REFERRAL
EARLY INFLAMMATORY ARTHRITIS

Related Articles

Cited By...

More in this TOC Section

  • Vasculitis: What Have We Learned in the Last 50 Years?
  • Demographic, Lifestyle, and Serologic Risk Factors for Rheumatoid Arthritis (RA)–associated Bronchiectasis: Role of RA-related Autoantibodies
  • The Association of Illness-related Uncertainty With Mental Health in Systemic Autoimmune Rheumatic Diseases
Show more Article

Similar Articles

Keywords

  • arthritis
  • TRIAGE
  • REFERRAL
  • EARLY INFLAMMATORY ARTHRITIS

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire